In May 2025, Hunan Jiudian Hongyang Pharmaceutical Co., Ltd., a subsidiary of Hunan Jiudian Pharmaceutical Co., Ltd., achieved a significant milestone by registering sodium dihydrogen phosphate heptahydrate with China’s National Medical Products Administration (NMPA). This development addresses a critical gap in the domestic supply of pharmaceutical-grade excipients, particularly essential for buffer solutions and renal therapies.
Market Dynamics: Strengthening Domestic Pharmaceutical Supply Chains
Sodium dihydrogen phosphate heptahydrate (NaH₂PO₄·7H₂O) is widely utilized in pharmaceutical formulations, including injection solutions and dialysis treatments. The registration by Hunan Jiudian Hongyang enhances China’s self-reliance in producing high-purity excipients, reducing dependency on imports and ensuring a stable supply for critical medical applications.
Export Landscape: China’s Position in the Global Market
China stands as a significant exporter of sodium dihydrogen phosphate, with export prices ranging between $1.39 and $1.61 per kilogram in 2024. This pricing reflects a competitive edge in the global market, catering to countries seeking cost-effective pharmaceutical excipients.
Company Profile: Hunan Jiudian Pharmaceutical Co., Ltd.
Established in 2001 and headquartered in Changsha, Hunan Jiudian Pharmaceutical Co., Ltd. specializes in the production of antibiotics, active pharmaceutical ingredients (APIs), and excipients. The company operates multiple subsidiaries, including Hunan Jiudian Hongyang Pharmaceutical Co., Ltd., focusing on high-quality APIs and excipients.
Competitive Landscape: Key Players in the Excipients Market
Hunan Jiudian faces competition from both domestic and international companies in the pharmaceutical excipients sector. Notable competitors include:
- Merck KGaA: A global leader in pharmaceutical chemicals and excipients.
- Sigma-Aldrich (now part of Merck): Renowned for a wide range of laboratory and pharmaceutical products.
- Aarti Drugs Limited: An Indian company specializing in APIs and pharmaceutical intermediates.
- GVK Biosciences Pvt. Ltd.: Offers contract research and manufacturing services, including excipient production.
Strategic Implications: Enhancing Global Competitiveness
The successful registration of sodium dihydrogen phosphate heptahydrate by Hunan Jiudian Hongyang not only strengthens China’s domestic pharmaceutical supply chain but also positions the company to expand its footprint in the global market. By offering competitively priced, high-quality excipients, Hunan Jiudian is poised to meet the growing international demand, particularly in emerging markets seeking reliable pharmaceutical ingredients.
